Zivo Bioscience, Inc. Common Stock
ZIVO
ZIVO was delisted on the 24th of November, 2023.
1 hedge funds and large institutions have $17.6K invested in Zivo Bioscience, Inc. Common Stock in 2026 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
42% less capital invested
Capital invested by funds: $30.1K → $17.6K (-$12.6K)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HNB
Huntington National Bank
Columbus,
Ohio
|
-$702 |
ZIVO Hedge Fund Activity: Q2 2026 in Review
1 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Zivo Bioscience, Inc. Common Stock (ZIVO) for Q2 2026, worth a combined $17.6K — down 42% from $30.1K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ZIVO and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Huntington National Bank, exiting entirely with an estimated $702 sold.
- 1 institutional investor held Zivo Bioscience, Inc. Common Stock (ZIVO) as of Q2 2026, down from 2 in Q1 2026.
- Funds reported $17.6K of Zivo Bioscience, Inc. Common Stock stock for Q2 2026, down 42% quarter-over-quarter.
- 0 funds opened new Zivo Bioscience, Inc. Common Stock positions in Q2 2026 and 1 closed out, a net change of -1 holder.
- The largest Zivo Bioscience, Inc. Common Stock seller in Q2 2026 was Huntington National Bank, an estimated $702 sold.
Based on aggregated 13F filings for Q2 2026.